Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Initial and evolutionary profile of adverse responders to an intensive weight loss intervention: the RESOLVE Study
Mélina Bailly1, Laurie Isacco1, Frédéric Dutheil2
1Laboratory of the Metabolic Adaptations to Exercise Under Physiological and Pathological Conditions (AME2P), Research Center for Human Nutrition Auvergne (CRNH), Clermont Auvergne University, Clermont-Ferrand, France.
Background:
There is a need to better identify adverse responders to weight-loss interventions. The aim of this study was to: 1) identify potential predictive factors of adverse responders to weight loss; and 2) follow their long-term evolution.
Methods:
One-hundred participants (56 females) with overweight (59.5±4.9 years) followed a 3-week intervention combining physical activity and diet followed by one-year monitoring, and were divided into three subgroups: 1) group A (N.=13) - "regainers" (weight regain during follow-up >100% of initial loss); 2) group B (N.=25) - "moderate regainers" (weight regain: 0-100%); and 3) group C (N.=46) - "weight relosers" (weight regain <0%). Body composition, food consumption, inflammatory and metabolic markers were assessed during the intervention and follow-up.
Results:
Baseline energy intake was lower in group A(1518±361kcal/day) vs. group B (1929±451kcal/day) (P=0.013) and C(1882±572kcal/day) (P=0.024). Group A initially presented a healthier metabolic profile and the total score of compliance (diet + physical activity) was lower in group A during follow-up (group A:38.3% vs. B:49.2%(P=0.007) and C:72.1% (P<0.001). Ghrelin levels tend to decrease and peptide YY (PYY) to increase during follow-up in groups B and C while blunted responses were obtained in A.
Conclusions:
Adverse responders might be characterized by a less unhealthy metabolic profile at baseline but also by less favorable changes in their satiety-regulating hormones during the one-year follow-up.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Obesity
Factors Affecting Drug Response: Overview
Clinical Trials: Overview
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

